ZERO is proud to partner with accredited continuing medical education (CME) providers to offer prostate cancer CME hours.
In this virtual event, a panel of experts in prostate cancer discuss the practical considerations of oral therapies and common adverse events associated with approved agents for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). This activity is intended for oncologists, urologists, nurses, nurse practitioners (NPs), pharmacists, and other interprofessional healthcare providers (HCPs) practicing globally who care for individuals with prostate cancer. Presented live on June 22, 2022. For more information and to view the webinar, click here. Available until July 26, 2023.
Join urologists and prostate-cancer experts Dr. Neal Shore and Dr. Michael Gorin to discuss the role of approved and emerging radiopharmaceuticals in the optimal management of prostate cancer. Panelists will compare newer radiotracers with conventional imaging and review recent safety and efficacy data on the integration of molecular imaging into all stages of prostate cancer in this 60 minute CME opportunity. Click here for more information and to view the webinar, available until May 3, 2023.
Coming Soon (Fall 2022)!
Creating a Roadmap for Modern Prostate Cancer Care: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision Making to Personalize Patient Care
Are you a healthcare provider who would like to have ZERO’s materials in your office? Request your free prostate cancer educational literature here!